Knowledge * Content Libraries * Papers

Papers

Clinical Subjects

Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis

Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis

Audrey SL Low, Deborah P M Symmons, Mark Lunt, Louise K Mercer, Chris P Gale,Kath D Watson, William G Dixon, Kimme L Hyrich, on behalf of British Society for Rheumatology Biologics Register for Rheumatoid Arthritis and the BSRBR Control Centre Consortium. Ann Rheum Dis Published Online First: 10 January 2017 doi:10.1136/annrheumdis-2016-209784
Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis

Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis

Audrey SL Low, Deborah P M Symmons, Mark Lunt, Louise K Mercer, Chris P Gale,Kath D Watson, William G Dixon, Kimme L Hyrich, on behalf of the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BSRBRRA) and the BSRBR Control Centre Consortium. Ann Rheum Dis Published Online First: 10 January 2017 doi:10.1136/annrheumdis-2016-209784 


Risk of lymphoma in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Risk of lymphoma in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Louise K Mercer, James B Galloway, Mark Lunt, Rebecca Davies, Audrey L S Low, William G Dixon,  Kath D Watson, BSRBR Control Centre Consortium, Deborah P M Symmons, Kimme L Hyrich
Ann Rheum Dis 2017;76:497–503
12345